fevarin
viatris healthcare limited - fluvoxamina - fluvoxamina
sertralina pensa
towa pharmaceutical s.p.a. - sertralina - sertralina
omtisa
g.l. pharma gmbh - metadone - metadone
dosertra
bruno farmaceutici s.p.a. - sertralina - sertralina
antaxone
zambon italia s.r.l. - naltrexone - naltrexone
nalorex
l. molteni & c. dei f.lli alitti societa' di esercizio s.p.a. - antidoti - antidoti
unitramarim
aziende chimiche riunite angelini francesco acraf spa - tramadolo - tramadolo
zydelig
gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.
naltrexin compresse rivestite con film
orpha swiss gmbh - naltrexonum - compresse rivestite con film - naltrexoni hydrochloridum 50.000 mg corresp. naltrexonum 45.2 mg, lactosum monohydricum 123.155 mg, cellulosi pulvis, cellulosum microcristallinum, silica colloidalis anhydrica, crospovidonum, magnesii stearas, Überzug: lactosum monohydricum 3.600 mg, hypromellosum, e 171, macrogolum 4000, e 172 (nigrum), e 172 (rubrum), e 172 (flavum), pro compresso obducto. - oppiacei antagonista allo svezzamento dopo la disintossicazione da opiatabhängigen, di alcolisti. - synthetika
torphadine
le vet beheer b.v. - tartrato di butorfanolo - tartrato di butorfanolo - 14.58 mg, butorfanolo tartrato - 14.58 mg - butorphanol